Late Recognition of Wolfram Syndrome Type 1 in Adulthood: Multisystemic Presentation with a Founder WFS1 Variant – A case report

Read full text
Authors: Elif Duygu Topan, Hilal Bektaş Uysal
Cited by: 0

Abstract

Background: Wolfram syndrome type 1 is a rare, autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is classically characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, but its clinical spectrum is highly heterogeneous. Delayed recognition is common, especially when features are misattributed to diabetes complications. Case Report: We present a 39-year-old man with insulin-dependent diabetes mellitus since adolescence, who developed progressive multisystem involvement including optic atrophy, neurogenic bladder with end-stage renal disease, psychiatric manifestations, and neurological complications. Despite early diabetes onset, Wolfram syndrome was not suspected until late in the disease course. Genetic analysis revealed a homozygous missense variant in WFS1 (c.1672C>T; p.Arg558Cys), previously described as a founder mutation and classified as pathogenic according to the criteria of the American College of Medical Genetics and Genomics. The patient exhibited an incomplete phenotype, with optic atrophy and suspected central diabetes insipidus, but without documented sensorineural hearing loss. Despite multidisciplinary supportive care, the disease followed a relentlessly progressive course and the patient died due to multisystem failure. Conclusion: This case highlights the diagnostic challenges of Wolfram syndrome in adulthood, where overlapping features with diabetic complications may obscure recognition. Early genetic testing in patients with juvenile-onset diabetes and optic atrophy is critical for timely diagnosis, comprehensive surveillance, and appropriate counseling. Reporting adult-onset cases with founder variants contributes to expanding the clinical spectrum and emphasizes the importance of multidisciplinary management in this rare but devastating disorder.

Fields of Study & Subjects

Diabetes and associated disorders Genomics and Rare Diseases Metabolism and Genetic Disorders

Publication details

Journal / source
European Journal of Medical Case Reports
Volume
10
Issue
2
Pages
56–59
Publication date
4 February 2026
Language
EN